The Latest Cardiac and Vascular News
– Operating loss decreased vs. Q1 2020 – Net loss increased vs. Q1 2020 – ZanthoSyn® revenues decreased vs. Q1 2020 – Company pursuing multiple funding opportunities HONOLULU, May 14, 2021 /PRNewswire/ — Cardax, Inc. (OTCQB:CDXI) reported its Q1 2021 results. Highlights: Financial Results. Operating loss decreased from $906,031 in Q1 2020 to $771,312 in Q1 2021 […]
WARRINGTON, Pa., May 13, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the first quarter ended March 31, 2021 and provided key business updates. Key Business and Financial Updates Expanded the participating […]
Positive results from the landmark PzF SHIELD IDE clinical trial reinforce safe and effective use in a real-world clinical practice of the world’s first non-drug-eluting, nanocoated coronary stent. SAN ANTONIO, May 13, 2021 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its […]
TAMPA, Fla., May 12, 2021 /PRNewswire/ — Tampa General Hospital and USF Health’s Interventional Cardiology team has adopted new intravascular technology and successfully treated the first patient in the world. Tampa General has built a legacy as an early adopter of intravascular imaging for coronary intervention and continues to seek the newest and […]
Heart & Vascular Institute Expansion and Community Partnerships Lead to Decrease in Heart-Related Deaths EDGEWOOD, Ky., May 13, 2021 /PRNewswire/ — St. Elizabeth Healthcare is increasing access to quality cardiac care in the Northern Kentucky community with system-wide enhancements to the Heart & Vascular Institute (HVI), including the construction of a new, 67,000-square-foot facility in Edgewood and expansions to the […]
Expanded and Product Portfolio Strengthens Offering in Access and Therapy Guidance CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark Approval for a broad suite of […]
SAN CARLOS, Calif., May 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, today reported financial results for the first quarter of 2021 and filed its quarterly report on Form 10-Q for the three months ended March […]
– Doubled the market opportunity for Treprostinil Injection by adding subcutaneous delivery – Resubmitted New Drug Application for LIQ861 (treprostinil) Inhalation Powder – Improved financial position with private placement and access to new credit facility – Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., May […]
CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2021. Recent Highlights: Reported revenue of $3.6 million in the […]
Gentle Ultrafiltration with Aquadex SmartFlow® Expands Options for Pediatric Patients EDEN PRAIRIE, Minn., May 13, 2021 (GLOBE NEWSWIRE) — Reaffirming its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., today announced that its […]
